Prestige Consumer Healthcare Inc (PBH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 13.04 is considered Undervalued compared with the five-year average of 14.47. The fair price of Prestige Consumer Healthcare Inc (PBH) is between 110.35 to 123.83 according to relative valuation method. Compared to the current price of 68.53 USD , Prestige Consumer Healthcare Inc By Undervalued By 37.9%.

Relative Value

Fair Zone

110.35-123.83

Current Price：68.53

37.9%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Prestige Consumer Healthcare Inc (PBH) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Prestige Consumer Healthcare Inc (PBH) has a current Price-to-Book (P/B) ratio of 1.61. Compared to its 3-year average P/B ratio of 2.03, the current P/B ratio is approximately -20.65% higher. Relative to its 5-year average P/B ratio of 1.95, the current P/B ratio is about -17.37% higher. Prestige Consumer Healthcare Inc (PBH) has a Forward Free Cash Flow (FCF) yield of approximately 8.68%. Compared to its 3-year average FCF yield of 7.13%, the current FCF yield is approximately 21.79% lower. Relative to its 5-year average FCF yield of 7.62%, the current FCF yield is about 13.84% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for PBH competitors is 3.88, providing a benchmark for relative valuation. Prestige Consumer Healthcare Inc Corp (PBH.N) exhibits a P/S ratio of 2.64, which is -31.79% above the industry average. Given its robust revenue growth of -2.37%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of PBH increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of PBH in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is PBH currently overvalued or undervalued?

Prestige Consumer Healthcare Inc (PBH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 13.04 is considered Undervalued compared with the five-year average of 14.47. The fair price of Prestige Consumer Healthcare Inc (PBH) is between 110.35 to 123.83 according to relative valuation method. Compared to the current price of 68.53 USD, Prestige Consumer Healthcare Inc is Undervalued By 37.90%.

What is Prestige Consumer Healthcare Inc (PBH) fair value?

PBH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Prestige Consumer Healthcare Inc (PBH) is between 110.35 to 123.83 according to relative valuation method.

How does PBH's valuation metrics compare to the industry average?

The average P/S ratio for PBH's competitors is 3.88, providing a benchmark for relative valuation. Prestige Consumer Healthcare Inc Corp (PBH) exhibits a P/S ratio of 2.64, which is -31.79% above the industry average. Given its robust revenue growth of -2.37%, this premium appears unsustainable.

What is the current P/B ratio for Prestige Consumer Healthcare Inc (PBH) as of Mar 03 2026?

As of Mar 03 2026, Prestige Consumer Healthcare Inc (PBH) has a P/B ratio of 1.61. This indicates that the market values PBH at 1.61 times its book value.

What is the current FCF Yield for Prestige Consumer Healthcare Inc (PBH) as of Mar 03 2026?

As of Mar 03 2026, Prestige Consumer Healthcare Inc (PBH) has a FCF Yield of 8.68%. This means that for every dollar of Prestige Consumer Healthcare Inc's market capitalization, the company generates 8.68 cents in free cash flow.

What is the current Forward P/E ratio for Prestige Consumer Healthcare Inc (PBH) as of Mar 03 2026?

As of Mar 03 2026, Prestige Consumer Healthcare Inc (PBH) has a Forward P/E ratio of 13.04. This means the market is willing to pay $13.04 for every dollar of Prestige Consumer Healthcare Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Prestige Consumer Healthcare Inc (PBH) as of Mar 03 2026?

As of Mar 03 2026, Prestige Consumer Healthcare Inc (PBH) has a Forward P/S ratio of 2.64. This means the market is valuing PBH at $2.64 for every dollar of expected revenue over the next 12 months.

PBH Valuation